Page 3 - உலகளாவிய கூட்டணி க்கு மாற்றி அமைக்கத்தக்க ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from உலகளாவிய கூட்டணி க்கு மாற்றி அமைக்கத்தக்க ஆராய்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In உலகளாவிய கூட்டணி க்கு மாற்றி அமைக்கத்தக்க ஆராய்ச்சி Today - Breaking & Trending Today

(KTRA) - Kintara Stock Soars After Site Activation Update On Glioblastoma Trial

Kintara Therapeutics Inc (NASDAQ: KTRA) has announced that the VAL-083 treatment arm in the Global Coalition for Adaptive Research registrational Phase . ....

Global Coalition For Adaptive Research , Kintara Therapeutics Inc , Global Coalition , Adaptive Research , உலகளாவிய கூட்டணி க்கு மாற்றி அமைக்கத்தக்க ஆராய்ச்சி , உலகளாவிய கூட்டணி , மாற்றி அமைக்கத்தக்க ஆராய்ச்சி ,

Kintara Therapeutics Provides Positive Site Activation Update on GCAR Phase 2/3 Clinical Trial for Glioblastoma

Kintara Therapeutics Provides Positive Site Activation Update on GCAR Phase 2/3 Clinical Trial for Glioblastoma
News provided by
Share this article
Share this article
SAN DIEGO, May 26, 2021 /PRNewswire/ Kintara Therapeutics, Inc. (Nasdaq: KTRA) ( Kintara or the Company ), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that the VAL-083 treatment arm in the Global Coalition for Adaptive Research (GCAR) registrational Phase 2/3 clinical trial for glioblastoma multiforme (GBM) has been activated in 15 U.S. sites as of May 14, 2021.
The trial, titled GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment), is a patient-centered, adaptive platform trial for registration evaluating multiple therapies for patients with newly-diagnosed and recurrent GBM. Since January 2021, GCAR has accelerated the pace of clinical site activation with increased awareness in the medical community o ....

United States , San Diego , Jules Abraham , Sloan Kettering , Us National Cancer Institute , Global Coalition For Adaptive Research , Company Current Reports On Form , Emory University Winship Cancer Institute , Kintara Therapeutics Inc , University Of Florida , Company Quarterly Reports On Form , Company Annual Report On Form , Henry Ford Cancer Institute , Columbia University Irving Cancer Research Center , Kintara Therapeutics , Global Coalition , Adaptive Research , Saiid Zarrabian , Chief Executive , Memorial Sloan Kettering , Cancer Institute , Orphan Drug Designation , Orphan Drug Designations , Fast Track Designation , Private Securities Litigation Reform Act , Annual Report ,

BioBuzz celebrates Asian/Pacific American Heritage (AAPI) Month · BioBuzz

Asian/Pacific American Heritage (AAPI)
Month is celebrated annually during the month of May. It marks the celebration of Asians and Pacific Islanders in the United States. It includes people having origins from the continent of Asia and the Pacific islands of Melanesia and Polynesia. Asian Americans and Pacific Islanders have a rich culture and heritage spanning thousands of years that have shaped the modern history of the US.
AAPI Heritage commemoration was first proposed in 1977 to observe the immigration of the first Japanese to the US (May 7, 1843) and the completion of the transcontinental railroad, constructed mainly by Chinese immigrant workers (May 10, 1869). President Carter made it an annual week-long event in 1978, and eventually, President George H.W. Bush extended the proclamation to include the entire month of May. ....

New York , United States , Fountain Hills , Cornell University , University Of Delaware , San Diego , Kelvinh Lee , Yunato Wu , Sujuan Ba , Nancym Fleming , Yuntao Wu , Kelvin Lee , Georgehw Bush , Justin Yang , Global Coalition For Adaptive Research , Queen University , Chinese Medical Doctor Association , Membership Committee Of The International Union , Research Therapy , Institute Merieux , York State Center , Development Studie Global Health Programme , School Of Chemical , George Mason University , Scientific Advisory Boards Of Medelis Inc , Cornell Institute For Biotechnology ,

Kintara Therapeutics Inc ends fiscal third quarter with cash and cash equivalents of about $15.7 million

Kintara Therapeutics ends fiscal 3Q with cash and cash equivalents of about $15.7M
The capital runway is expected to be sufficient to fund the company s planned operations to the second quarter of calendar year 2022
Kintara achieved the healthy cash stockpile primarily due to the exercise of warrants as well as operational and resource synergies realized through the Adgero Biopharmaceuticals merger in August 2020
Kintara Therapeutics Inc (NASDAQ:KTRA), which is focused on the development of new solid tumor cancer therapies, said it closed its fiscal third quarter with cash and cash equivalents of about $15.7 million.
That capital, the company said, is expected to be sufficient to fund its planned operations to the second quarter of calendar year 2022. ....

Global Coalition For Adaptive Research , Kintara Therapeutics Inc , Adgero Biopharmaceuticals Holdings Inc , Global Coalition , Adaptive Research , உலகளாவிய கூட்டணி க்கு மாற்றி அமைக்கத்தக்க ஆராய்ச்சி , உலகளாவிய கூட்டணி , மாற்றி அமைக்கத்தக்க ஆராய்ச்சி ,

Kintara Presents Updates on Two Phase 2 Clinical Trials at the 2021 American Association for Cancer Research Annual Meeting

Kintara Presents Updates on Two Phase 2 Clinical Trials at the 2021 American Association for Cancer Research Annual Meeting
News provided by
Share this article
Share this article
SAN DIEGO, April 12, 2021 /PRNewswire/ Kintara Therapeutics, Inc. (Nasdaq: KTRA) ( Kintara or the Company ), a biopharmaceutical company developing novel cancer therapies for patients who are failing, or resistant to, current treatment regimens, today announced interim data results from two Phase 2 clinical trials evaluating VAL-083, the Company s lead compound, for the treatment of glioblastoma multiforme (GBM). The data were presented in two posters at the 2021 American Association for Cancer Research (AACR) Annual Meeting, which is taking place virtually from April 10-15, 2021. ....

United States , San Diego , N Eng Jmed , Jules Abraham , National Cancer Institute , Global Coalition For Adaptive Research , Company Current Reports On Form , Kintara Therapeutics Inc , Md Anderson Cancer Center , Company Quarterly Reports On Form , Sun Yat Sen University Cancer Center , Company Annual Report On Form , American Association For Cancer Research , Kintara Therapeutics , Cancer Research , Annual Meeting , Cancer Center , Saiid Zarrabian , Chief Executive , Global Coalition , Adaptive Research , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports , ஒன்றுபட்டது மாநிலங்களில் ,